Search

Your search keyword '"Vinther-Jensen, Tua"' showing total 28 results

Search Constraints

Start Over You searched for: Author "Vinther-Jensen, Tua" Remove constraint Author: "Vinther-Jensen, Tua" Language english Remove constraint Language: english
28 results on '"Vinther-Jensen, Tua"'

Search Results

3. Impairments of social cognition significantly predict the progression of functional decline in Huntington's disease: A 6-year follow-up study.

7. Clinical and genetic characteristics of late-onset Huntington's disease

8. Reduced Cancer Incidence in Huntington's Disease: Analysis in the Registry Study

9. Early Intrathecal T Helper 17.1 Cell Activity in Huntington Disease.

10. Hybrid 2-[18F] FDG PET/MRI in premanifest Huntington's disease gene-expansion carriers: The significance of partial volume correction.

11. Cognitive Screening Tests in Huntington Gene Mutation Carriers: Examining the Validity of the Mini-Mental State Examination and the Montreal Cognitive Assessment.

14. Defining active progressive multiple sclerosis.

16. Liver function in Huntington's disease assessed by blood biochemical analyses in a clinical setting.

18. Assessing Impairment of Executive Function and Psychomotor Speed in Premanifest and Manifest Huntington’s Disease Gene-expansion Carriers.

19. A clinical classification acknowledging neuropsychiatric and cognitive impairment in Huntington's disease.

20. Germ-line CAG repeat instability causes extreme CAG repeat expansion with infantile-onset spinocerebellar ataxia type 2.

22. Reduction in mitochondrial DNA copy number in peripheral leukocytes after onset of Huntington's disease.

23. Identification of genetic variants associated with Huntington's disease progression

24. Clinical manifestations of intermediate allele carriers in Huntington disease

25. Hybrid 2-[18F] FDG PET/MRI in premanifest Huntington's disease gene-expansion carriers: The significance of partial volume correction.

26. Early Intrathecal T Helper 17.1 Cell Activity in Huntington Disease.

27. Defining active progressive multiple sclerosis.

28. Selected CSF biomarkers indicate no evidence of early neuroinflammation in Huntington disease.

Catalog

Books, media, physical & digital resources